How PX1 Tests Every MOTS-C Lot (HPLC, MS, Endotoxin)
Ensuring reproducibility in mitochondrial research requires absolute clarity regarding peptide identity, purity, and salt content. Every batch of PX1 MOTS-c undergoes an exhaustive third-party analytical stack—including RP-HPLC, high-resolution mass spectrometry, and chromogenic endotoxin testing—to guarantee uncompromised quality for laboratory applications.
Quick answer
Ensuring reproducibility in mitochondrial research requires absolute clarity regarding peptide identity, purity, and salt content. Every batch of PX1 MOTS-c undergoes an exhaustive third-party analytical stack—including RP-HPLC, high-resolution mass spectrometry, and chromogenic endotoxin testing—to guarantee uncompromised quality for laboratory applications.
Key takeaways
- [MOTS-c](/research-peptides/mots-c) (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome.
- The primary benchmark for peptide purity is Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).
- While RP-HPLC establishes chemical purity by isolating individual chromatographic peaks, Mass Spectrometry (MS) is required to confirm the precise molecular identity of the target analyte.
- A common point of confusion in peptide biochemistry is the distinction between gross solid mass and net peptide content.
The Need for Rigorous Analytical Verification in MOTS-c Research
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome. In preclinical models, MOTS-c has been investigated for its unique role in mitochondrial function, metabolic regulation, and exercise-capacity research. Because mitochondrial pathways are exceptionally sensitive to structural variants, organic impurities, and bacterial pyrogens, utilizing a verified, high-purity research compound is paramount to establishing accurate experimental baselines.
When purchasing compounds for cellular assays or rodent models, verifying that your batch of MOTS-c is third party tested provides the quantitative confidence necessary to attribute observed biochemical outcomes directly to the peptide sequence rather than manufacturing artifacts. PX1 Research implements a comprehensive lot-by-lot testing protocol executed by independent ISO 17025-accredited laboratories to ensure batch-to-batch consistency across our entire research peptide catalog.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) Purity Analysis
The primary benchmark for peptide purity is Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). RP-HPLC separates the target peptide from synthesis byproducts, such as truncation sequences, deletion peptides, and side-chain modified impurities, based on hydrophobic interactions with a stationary column matrix.
During HPLC analysis of PX1 MOTS-c, the sample is eluted through a specialized C18 column using a mobile phase gradient of water and acetonitrile supplemented with 0.1% trifluoroacetic acid (TFA). UV detection at 214 nm or 220 nm records the absorbance profile. Our strict quality control standard mandates that the integrated area percentage of the main target peak must account for at least 98.0% of the total chromatogram area. Any lot displaying minor impurity peaks exceeding pre-specified thresholds is automatically rejected before entering distribution.
Structural Identity Verification via High-Resolution Mass Spectrometry (MS)
While RP-HPLC establishes chemical purity by isolating individual chromatographic peaks, Mass Spectrometry (MS) is required to confirm the precise molecular identity of the target analyte. For a peptide like MOTS-c, structural verification ensures that the 16-amino-acid sequence (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg) has been synthesized without sequence inversions or incorrect amino acid substitutions.
PX1 utilizes Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry. The resulting mass spectrum reveals the exact mass-to-charge ratio (m/z) of the molecular ion. By comparing the experimentally observed molecular weight against the theoretical monoisotopic mass of MOTS-c (2174.6 Da), our analytical partners confirm identity to within sub-Dalton precision, providing definitive evidence of correct primary structure for downstream laboratory research.
Quantitative Peptide Content and Counterion Determination
A common point of confusion in peptide biochemistry is the distinction between gross solid mass and net peptide content. Lyophilized peptides naturally retain residual moisture and counterions (such as acetate or trifluoroacetate) resulting from the purification process. Consequently, a vial containing 5 mg of lyophilized powder does not consist of 5.0 mg of pure amino acid mass.
To provide researchers with exact gravimetric data, PX1 analytical reports specify the net peptide content determined via elemental nitrogen analysis or quantitative HPLC against an authentic reference standard. Knowing the exact net peptide percentage allows investigators to prepare accurate molar solutions when performing sensitive quantitative assays. Researchers can easily calculate precise working concentrations using our integrated reconstitution calculator.
Biological Safety: Chromogenic LAL Endotoxin Quantification
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent stimulators of immune responses in mammalian cells. In cell culture assays or animal studies evaluating metabolic markers, even trace quantities of endotoxin can induce inflammatory cascades, corrupting experimental data and compromising cell viability.
Every batch of PX1 MOTS-c undergoes kinetic chromogenic Limulus Amebocyte Lysate (LAL) testing. This assay measures the enzymatic cleavage of a synthetic substrate in the presence of endotoxins, yielding a quantitative measure expressed in Endotoxin Units per milligram (EU/mg). PX1 enforces strict limits (<0.01 EU/µg), ensuring that our research compounds are suitable for sensitive biological systems without introducing confounding immune-mediated artifacts.
Aseptic Processing, Sterility, and Lyophilization Protocols
Purity testing extends beyond chemical composition to encompass physical container integrity and microbiological sterility. PX1 peptides are manufactured in GMP-compliant facilities utilizing automated, validated aseptic filling suites. The solution is sterile-filtered through 0.22-micron membranes prior to controlled lyophilization.
Lyophilization removes solvent under deep vacuum, yielding a stable, uniform cake optimized for extended shelf life. Vials are stoppered under inert gas (argon or nitrogen) to protect the sequence from oxidative degradation. Random samples from each production run undergo sterility testing to confirm the complete absence of microbial growth, ensuring that researchers receive stable, uncompromised material.
Retained Sample Archives and Lot Traceability Systems
Quality assurance requires long-term accountability. For every lot of MOTS-c manufactured, PX1 retains dual archival samples stored at -80°C in climate-monitored conditions. These retained samples serve as historical benchmarks for ongoing stability monitoring and secondary auditing.
Our centralized lot traceability system links every individual vial back to its specific synthesis batch, raw material origin, purification logs, and independent laboratory COA. Institutional laboratories sourcing through our wholesale program benefit from complete chain-of-custody transparency, ensuring that longitudinal studies running over months or years maintain identical material inputs.
Comparative Overview: MOTS-c vs. Related Mitochondrial Compounds
When designing preclinical protocols around mitochondrial bioenergetics, researchers frequently compare MOTS-c with other signal peptides targeting metabolic and organellar pathways. Understanding how these compounds differ structurally and functionally helps refine experimental models.
While MOTS-c acts primarily as a nuclear-translocating signaling peptide involved in metabolic regulation and stress responses in rodent models, compounds like SS-31 (Elamipretide) target cardiolipin within the inner mitochondrial membrane to optimize electron transport chain efficiency. Similarly, Humanin, another mitochondrial-derived peptide, is frequently evaluated for cytoprotective and anti-apoptotic pathways. Accessing robustly tested compounds across this entire class allows comparative researchers to isolate specific mitochondrial mechanisms with high analytical confidence.
How to Read and Verify Your PX1 MOTS-c Certificate of Analysis
Every shipment of PX1 research peptides includes access to lot-specific documentation. To match your vial with its verified analytical stack, locate the lot number printed directly on the vial label and navigate to our public COA lookup database.
When auditing a MOTS-c COA, verify three primary metrics: first, confirm that the ESI-MS mass spectrum matches the theoretical mass of 2174.6 Da; second, ensure the RP-HPLC chromatogram displays a clear dominant peak representing ≥98% purity; third, review the LAL endotoxin result to confirm levels fall below the required threshold for your assay type. This transparent verification loop ensures absolute compliance with institutional lab standards.
Laboratory Storage, Reconstitution, and Handling Guidelines
To preserve the chemical stability of MOTS-c following receipt, lyophylized vials should be stored at -20°C for short-term projects or -80°C for long-term archiving, protected from light and atmospheric moisture. Avoid exposing unopened vials to ambient humidity before thermal equilibration to prevent condensation formation inside the container.
Reconstitution should be performed using sterile, laboratory-grade solvents such as Bacteriostatic Water or Sterile Water for Injection, depending on experimental requirements. Aliquoting the reconstituted stock solution into single-use microcentrifuge tubes minimizes repeated freeze-thaw cycles, which can induce peptide aggregation or peptide bond hydrolysis over time.
Frequently Asked Questions
What analytical methods are used to test PX1 MOTS-c?
Every lot of PX1 MOTS-c undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination, Electrospray Ionization Mass Spectrometry (ESI-MS) for molecular identity, and kinetic chromogenic LAL testing for endotoxin quantification.
How do I match my vial of MOTS-c to its COA?
Each vial features a distinct lot number printed on the label. Input this lot number into the PX1 online COA repository to view and download the full, unedited third-party laboratory analytical report.
What purity level is guaranteed for PX1 MOTS-c?
PX1 guarantees a minimum target purity of 98.0% by HPLC area percentage for every distributed batch of MOTS-c.
Why is endotoxin testing critical for MOTS-c in laboratory research?
Endotoxins (LPS) trigger inflammatory signals in cell cultures and animal models, potentially masking or distorting the metabolic and mitochondrial mechanisms under investigation. Low-endotoxin certified peptides prevent these experimental artifacts.
What is the difference between gross mass and net peptide content?
Gross mass includes the target peptide along with residual counterions (like TFA or acetate) and moisture. Net peptide content reflects the actual percentage of pure amino acid chain mass, which is critical for accurate molar calculation.
How should reconstituted MOTS-c be stored in the lab?
Reconstituted MOTS-c should be divided into single-use aliquots and stored at -20°C or -80°C to prevent degradation from repeated freeze-thaw cycles.
Where are PX1 research peptides manufactured and shipped from?
PX1 peptides are manufactured in state-of-the-art, GMP-compliant facilities in the USA and shipped directly from our primary distribution hubs in California and Arizona.
Can PX1 MOTS-c be used for clinical or therapeutic applications?
No. PX1 compounds are strictly intended for laboratory research use only by qualified scientific personnel. They are not for human, clinical, or veterinary diagnostic or therapeutic use.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.